ラニナミビル
1. laninamivir (influenza medication)Pharmacology
2. LaninamivirLaninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. It is currently in Phase III clinical trials. Laninamivir was approved for influenza treatment in Japan in 2010 and is currently marketed under the name "Inavir" by Daiichi Sankyo. Biota Holdings Ltd and Daiichi Sankyo co-own Laninamivir.
Read “Laninamivir” on English Wikipedia
Read “ラニナミビル” on Japanese Wikipedia
Read “Laninamivir” on DBpedia
Read “Laninamivir” on English Wikipedia
Read “ラニナミビル” on Japanese Wikipedia
Read “Laninamivir” on DBpedia
Discussions
Log in to talk about this word.